腎比達 | 合法藥品大搜索

腎比達 ®，是專為貓慢性腎病設計的治療藥物，能透過調控和慢性腎病相關的內分泌系統，有效地治療貓的腎性蛋白尿，減緩慢性腎病的惡化，成為治腎關鍵。而獨特的口服液藥水 ... Read More

Semintra ® 腎比達 · Telmisartan，4mg/mL，每瓶30mL。 · 貓蛋白尿治療劑量為每天一次，每次1mg/kg(=0.25mL/kg)。 · 口服液劑型，直接滴入口中或少量食物一同給予。 · 食物不 ... Read More

SEMINTRA is a highly targeted treatment ... Telmisartan, the active substance in SEMINTRA, is an ARB, a class of medication that modulates the RAAS by selectively ... Read More

Semintra is a veterinary medicine used in cats to reduce proteinuria (protein in the urine) and to treat high blood pressure. Proteinuria can occur with ... Read More

2013年2月13日 — Semintra 4 mg/ml oral solution for cats. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION. One ml contains: Active substance: Telmisartan. Read More

Semintra ®. 4mg/ml – Management of chronic kidney disease (CKD) in cats: for reduction of proteinuria associated with CKD in cats. Read More

Semintra 4mg/ml 30ml for Cat 貓貓口服溶液，有助於減少貓尿中蛋白質的損失。 Semintra是一種專為貓設計的口服溶液，含有一種名為Telmisartan。 Semintra有助於減少貓 ... Read More

The safety of telmisartan has not been established in breeding, pregnant or lactating cats or in cats under the age of 6 months. Side effects. Semintra® is well ... Read More

2018年10月2日 — 1-3 Designed to make management of feline hypertension easier for cat owners and veterinarians, SEMINTRA is the only FDA-approved treatment for ... Read More